数据链接：
官方服务：
资源简介：
Tumor responses and BRAF mutational status.
应用场景：
创建时间：
2010-12-29
相关数据集
Investigating a novel multiplex proteomics technology for detection of changes in serum protein concentrations that may correlate to tumor burden
We applied the Quantibody® Human Kiloplex Array to measure 1,000 proteins in sera obtained pre- and post-surgically from 5 pancreatic cancer patients. Sera from two healthy individuals, split into two
NIAID Data Ecosystem60
Table_3_A New Oxaliplatin Resistance-Related Gene Signature With Strong Predicting Ability in Colon Cancer Identified by Comprehensive Profiling.XLSX
Numerous colon cancer cases are resistant to chemotherapy based on oxaliplatin and suffer from relapse. A number of survival- and prognosis-related biomarkers have been identified based on database mi
NIAID Data Ecosystem40
DataSheet_1_A novel risk score model based on gamma-aminobutyric acid signature predicts the survival prognosis of patients with breast cancer.zip
BackgroundGamma-aminobutyric acid (GABA) participates in the migration, differentiation, and proliferation of tumor cells. However, the GABA-related risk signature has never been investigated. Hence,
NIAID Data Ecosystem10
IMCISION DNAseq
Standard-of-care (SOC) surgery for locoregionally advanced head and neck squamous cell carcinoma (HNSCC) is intensive and results in 30‒50% five-year overall survival. Anti-PD1 immune checkpoint
NIAID Data Ecosystem40
DataSheet2_TRPV4 is a Prognostic Biomarker that Correlates with the Immunosuppressive Microenvironment and Chemoresistance of Anti-Cancer Drugs.xlsx
Background: Transient receptor potential cation channel subfamily V member 4 (TRPV4) has been reported to regulate tumor progression in many tumor types. However, its association with the tumor immune
NIAID Data Ecosystem20
